These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 5402999)

  • 21. [Primary resistance in adult pulmonary tuberculosis in France. 3d report of the study center on Primary Resistance: 1966-1970].
    Canetti G; Le Lirzin M; Gay P; Thibier R; Kreis B; Grosset J
    Rev Tuberc Pneumol (Paris); 1972; 36(3):337-56. PubMed ID: 5080965
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative study of 2 therapeutic schemes in pulmonary tuberculosis not previously treated].
    Galleguillos F; Valenzuela P; Carrasco E; Ham O; Ihnen R
    Rev Med Chil; 1973 Jan; 101(1):25-9. PubMed ID: 4753547
    [No Abstract]   [Full Text] [Related]  

  • 23. [Remote results of treatment of newly identified patients with tuberculosis of the respiratory organs].
    Shipin GE
    Probl Tuberk; 1974; (10):13-7. PubMed ID: 4423236
    [No Abstract]   [Full Text] [Related]  

  • 24. Rifampin therapy of pulmonary tuberculosis in patients not treated previously with antituberculous drugs.
    Eidus L; Jessamine AG; Helbaque DM; Narasimhan V
    Int J Clin Pharmacol; 1974 Jan; 9(1):81-6. PubMed ID: 4593132
    [No Abstract]   [Full Text] [Related]  

  • 25. [Organization and effectiveness of the treatment of patients with newly detected destructive pulmonary tuberculosis].
    Beĭda MM; Dummich IuA; Shimko EP; Pashchenko SI; Donchenko VL
    Sov Med; 1973 Oct; 36(10):150. PubMed ID: 4789206
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528
    [No Abstract]   [Full Text] [Related]  

  • 27. [Early and late results of massive antitubercular chemotherapy in previously untreated pulmonary tuberculosis in adults].
    Sosnowski W; Kubiak Z
    Gruzlica; 1972 Jan; 40(1):21-8. PubMed ID: 5011722
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical and therapeutic remarks on latero-cervical adenopathies of tubercular origin].
    Gandolfi M; Rucco B; Bagnariol V
    Ann Laringol Otol Rinol Faringol; 1967; 66(6):925-41. PubMed ID: 5307059
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum transaminase levels in pulmonary tuberculosis. Effect of triple treatment with 4-4 1-di-isoamyloxythiocarbanilide or PAS in combination with streptomycin and isoniazid.
    Ockerman PA; Ryde C
    Scand J Respir Dis; 1968; 49(1):35-41. PubMed ID: 5187250
    [No Abstract]   [Full Text] [Related]  

  • 30. [Controlled therapeutic study of 5 intermittent chemotherapy regimens for pulmonary tuberculosis. 4th international study of the UICT].
    Bignall JR
    Bull Int Union Tuberc; 1974; 49(1):422-6. PubMed ID: 4143179
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of the aerosol inhalations of some antibacterial preparations on the cocco bacterial flora of the respiratory tract in pulmonary tuberculosis].
    Kulik NM
    Antibiotiki; 1976 Jun; 21(6):549-52. PubMed ID: 942196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Blood bacteriostatic activity in patients depending on the type of inactivation of isonicotinic acid hydrazide in the body].
    Gil'madinova RSh; Bakanova DIa
    Antibiotiki; 1971 Jan; 16(1):87-90. PubMed ID: 4994900
    [No Abstract]   [Full Text] [Related]  

  • 33. [Interrupted treatment with streptomycin and tubazid of patients with pulmonary tuberculosis].
    Ginzburg EA; Levtonova EV; Kaliamova RF; Shilova MV; Samarin MS
    Vrach Delo; 1973 Feb; 2():66-9. PubMed ID: 4722335
    [No Abstract]   [Full Text] [Related]  

  • 34. [Follow-up studies up to 2 years of pulmonary tuberculosis patients submitted to the primary chemotherapy for 1 year with multiple drugs including ethambutol].
    Kekkaku; 1973 Apr; 48(4):135-41. PubMed ID: 4721805
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evaluation of high dose INH twice weekly regimen in the original treatment for moderately advanced pulmonary tuberculosis. A report of the 12th series B study of the controlled trials].
    Kekkaku; 1972 Jun; 47(6):159-66. PubMed ID: 4562924
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immediate results obtained with intermittent treatment with classical tuberculostatic drugs in tuberculosis in children].
    Tonceanu S; Carp G; Bazacliu E; Sabău I
    Ftiziologia; 1974 May; 23(3):265-8. PubMed ID: 4546327
    [No Abstract]   [Full Text] [Related]  

  • 37. Pulmonary tuberculosis in well-treated alcoholics. Long-term prognosis regarding relapses compared with non-alcoholic patients.
    Kok-Jensen A
    Scand J Respir Dis; 1972; 53(4):202-6. PubMed ID: 4640658
    [No Abstract]   [Full Text] [Related]  

  • 38. [Proceedings: Current status and perspectives of tuberculosis chemotherapy in Algeria].
    Larbaoui D; Chaulet P
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):139-46. PubMed ID: 4491711
    [No Abstract]   [Full Text] [Related]  

  • 39. [Proceedings: Rifampicin adverse effects in intermittent therapy].
    Herrmann H; Eule H; Lau W; Kuhnert R; Fanter D; Kahlau U; Schönert E; Werner E
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):146-58. PubMed ID: 4491712
    [No Abstract]   [Full Text] [Related]  

  • 40. [State of the cardiovascular system after successfully completed drug therapy of pulmonary tuberculosis].
    Piatnochka IT
    Probl Tuberk; 1972; 50(5):50-1. PubMed ID: 5029679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.